GFAP and autism: Nevertheless, given that there are some clinical reports indicating that the expression levels of microglia (TREM2, Cx3CR1) and astroglia markers (mainly GFAP) may contribute to autism pathology (Edmonson et al., 2014), suggest that astrocyte dysfunction may underlie the ASD phenotype observed here.